Nebulizer Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Segmented by Device Type: Compressor/Jet, and Vibrating
Throughout this medical market research, the publisher analyzed Nebulizer companies across more than 70 countries and used their comprehensive methodology to understand the Market Sizes, Unit Sold, Average Selling Prices, Company Market Shares, and to create Accurate Forecasts.
The global nebulizer market was influenced in a positive way by COVID-19 in 2020 and is expected to continue growing over the forecast period to reach $321.8 million at a CAGR of 0.7% by 2027.
The majority of the global nebulizer market share was controlled by Omron, PARI, and Philips Healthcare.
A nebulizer is a piece of equipment used to assist breathing when the lung is affected by diseases such as asthma, cystic fibrosis, and other respiratory conditions. The market for nebulizers typically corresponds to the delivery of asthma medications to anyone who has difficulty using a standard asthma inhaler. This global market research spans over 70 countries and includes compressor/jet nebulizers and vibrating nebulizers.
Within this market, compressor variations represented the vast majority of the units sold, as they are inexpensive devices. While their higher price points can deter some customers, the ultrasonic and vibrating mesh variations have benefits that are gaining recognition, therefore stimulating growth in the market. COVID-19 did not have as significant an impact on the nebulizer market as it did on other segments, but it still did have a positive effect, resulting in double-digit growth in 2020.
The global ventilator market was controlled by Omron, PARI, and Philips Healthcare.
Omron was the leading competitor in the total nebulizer market, with popular offerings in the ultrasonic nebulizer and vibrating mesh nebulizer markets. The company's Micro Air® NE-U100 device is one of the smallest vibrating mesh nebulizers available on the market, making it a convenient alternative to metered-dose inhalers.
Throughout this report, iData Research has covered over 70 countries across the globe in great detail. The regions covered are: